Tryg A/S
Tryg A/S (TGVSF) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Tryg A/S (TGVSF), covering cash flow, earnings, and balance sheets.
Tryg A/S (TGVSF) Income Statement & Financial Overview
Review Tryg A/S TGVSF income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $10.05B | $9.28B | $10.56B | $10.37B |
| Cost of Revenue | $0.00 | $0.00 | $327.00M | $0.00 |
| Gross Profit | $10.05B | $9.28B | $10.23B | $10.37B |
| Gross Profit Ratio | $1.00 | $1.00 | $0.97 | $1.00 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $0.00 | $0.00 | $3.90B | $0.00 |
| Operating Expenses | $8.56B | $8.24B | $3.90B | $464.00M |
| Total Costs & Expenses | $8.56B | $8.24B | $3.90B | -$7.87B |
| Interest Income | $325.00M | $260.00M | $330.00M | $344.00M |
| Interest Expense | $0.00 | $0.00 | $0.00 | $94.00M |
| Depreciation & Amortization | $222.00M | $225.00M | $236.00M | $233.00M |
| EBITDA | $0.00 | $0.00 | $6.83B | $0.00 |
| EBITDA Ratio | $0.00 | $0.00 | $0.65 | $0.00 |
| Operating Income | $1.49B | $1.04B | $6.83B | $2.33B |
| Operating Income Ratio | $0.15 | $0.11 | $0.65 | $0.22 |
| Other Income/Expenses (Net) | -$1.00M | -$3.00M | -$4.70B | -$325.00M |
| Income Before Tax | $1.49B | $1.03B | $2.13B | $2.17B |
| Income Before Tax Ratio | $0.15 | $0.11 | $0.20 | $0.21 |
| Income Tax Expense | $373.00M | $247.00M | $523.00M | $486.00M |
| Net Income | $1.12B | $713.00M | $1.61B | $1.64B |
| Net Income Ratio | $0.11 | $0.08 | $0.15 | $0.16 |
| EPS | $1.81 | $1.16 | $2.62 | $2.67 |
| Diluted EPS | $1.80 | $1.16 | $2.62 | $2.67 |
| Weighted Avg Shares Outstanding | $609.68M | $612.47M | $615.26M | $615.71M |
| Weighted Avg Shares Outstanding (Diluted) | $609.92M | $612.63M | $615.35M | $615.71M |
Over the last four quarters, Tryg A/S achieved steady financial progress, growing revenue from $10.37B in Q2 2024 to $10.05B in Q1 2025. Gross profit stayed firm with margins at 100% in Q1 2025 versus 100% in Q2 2024. Operating income totaled $1.49B in Q1 2025, maintaining a 15% margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at $0.00. Net income rose to $1.12B, with EPS at $1.81. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan